Astria Therapeutics, Inc. (ATXS) Misses Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Join SI Premium – FREE
Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q2 EPS of ($0.57), $0.08 worse than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- FuelCell Energy (FCEL) Misses Q3 EPS by 24c
- Yatsen Holding (YSG) Reports Q2 Loss of $0.16
Create E-mail Alert Related Categories
Earnings, Mergers and AcquisitionsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
